Cargando…
Beneficial immune-modulatory effects of the N-163 strain of Aureobasidium pullulans-produced 1,3-1,6 Beta glucans in Duchenne muscular dystrophy: Results of an open-label, prospective, exploratory case-control clinical study
BACKGROUND: This exploratory case-control study is to evaluate the effects of supplementation of Aureobasidium pullulans-N-163 strain produced 1,3–1,− 6 beta glucan in young patients with Duchenne muscular dystrophy (DMD). METHODS: Twenty-seven male subjects aged 5–19 years with DMD were included, n...
Autores principales: | Raghavan, Kadalraja, Dedeepiya, Vidyasagar Devaprasad, Srinivasan, Subramaniam, Pushkala, Subramanian, Bharatidasan, Sudhakar S., Ikewaki, Nobunao, Iwasaki, Masaru, Senthilkumar, Rajappa, Preethy, Senthilkumar, Abraham, Samuel J.K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10694341/ http://dx.doi.org/10.1016/j.ibneur.2023.06.007 |
Ejemplares similares
-
Corrigendum to “Beneficial immune-modulatory effects of the N-163 strain of Aureobasidium pullulans-produced 1,3-1,6 Beta glucans in Duchenne muscular dystrophy: Results of an open-label, prospective, exploratory case-control clinical study” [IBRO Neurosci. Rep. 15 (2023), pp. 90–99]
por: Raghavan, Kadalraja, et al.
Publicado: (2023) -
Beneficial effects of novel aureobasidium pullulans strains produced beta-1,3-1,6 glucans on interleukin-6 and D-dimer levels in COVID-19 patients; results of a randomized multiple-arm pilot clinical study
por: Raghavan, Kadalraja, et al.
Publicado: (2022) -
Hepatoprotective Effects of Aureobasidium pullulans Derived β 1,3–1,6 Glucans in a Murine Model of Non-alcoholic Steatohepatitis
por: Ikewaki, Nobunao, et al.
Publicado: (2022) -
Improvement of behavioural pattern and alpha-synuclein levels in autism spectrum disorder after consumption of a beta-glucan food supplement in a randomised, parallel-group pilot clinical study
por: Raghavan, Kadalraja, et al.
Publicado: (2022) -
Benefits of Gut Microbiota Reconstitution by Beta 1,3–1,6 Glucans in Subjects with Autism Spectrum Disorder and Other Neurodegenerative Diseases
por: Raghavan, Kadalraja, et al.
Publicado: (2023)